UK MDA (Medical Devices Agency) warns of respiratory device misassembly:
This article was originally published in Clinica
Executive Summary
The UK Medical Devices Agency (MDA) has renewed warnings of the danger of using misassembled endotracheal and tracheostomy tubes, in light of "an increasing number of reports of barotrauma". In a hazard notice issued last week, the MDA urges that whenever respiratory therapy devices are connected to endotracheal or tracheostomy tubes, staff ensure there is free passage of expired gases and that assembly be undertaken only by appropriately trained staff. The agency reports two new related incidents, with "serious consequences". In one case, a disposable nebuliser chamber was connected directly onto the patient's tracheal tube. In the other, an oxygen therapy connector was connected to a breathing system filter, directly attached to the patient's endotracheal tube. Incorrectly assembling a respiratory therapy device to a tight-fitting facemask poses similar hazards.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.